Literature DB >> 10996218

Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice.

P F Stahel1, K Kariya, E Shohami, S R Barnum, H Eugster, O Trentz, T Kossmann, M C Morganti-Kossmann.   

Abstract

The anaphylatoxin C5a is a potent mediator of inflammation in the CNS. We analyzed the intracerebral expression of the C5a receptor (C5aR) in a model of closed head injury (CHI) in mice. Up-regulation of C5aR mRNA and protein expression was observed mainly on neurons in sham-operated and head-injured wild-type mice at 24 h. In contrast, in TNF/lymphotoxin-alpha knockout mice, the intracerebral C5aR expression remained at low constitutive levels after sham operation, whereas it strongly increased in response to trauma between 24 and 72 h. Interestingly, by 7 days after CHI, the intrathecal C5aR expression was clearly attenuated in the knockout animals. These data show that the posttraumatic neuronal expression of the C5aR is, at least in part, regulated by TNF and lymphotoxin-alpha at 7 days after trauma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996218     DOI: 10.1016/s0165-5728(00)00304-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

1.  Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients.

Authors:  Xin Cheng; Libang Yang; Ping He; Rena Li; Yong Shen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

3.  Exercise pre-conditioning reduces brain inflammation and protects against toxicity induced by traumatic brain injury: behavioral and neurochemical approach.

Authors:  Bibiana Castagna Mota; Leticia Pereira; Mauren Assis Souza; Luiz Fernando Almeida Silva; Danieli Valnes Magni; Ana Paula Oliveira Ferreira; Mauro Schneider Oliveira; Ana Flávia Furian; Leidiane Mazzardo-Martins; Morgana Duarte da Silva; Adair Roberto Soares Santos; Juliano Ferreira; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

4.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

5.  Mouse closed head injury model induced by a weight-drop device.

Authors:  Michael A Flierl; Philip F Stahel; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Esther Shohami
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

6.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.

Authors:  Sheng-Tao Yao; Fang Cao; Jia-Lin Chen; Wei Chen; Rui-Ming Fan; Gang Li; You-Chao Zeng; Song Jiao; Xiang-Ping Xia; Chong Han; Qi-Shan Ran
Journal:  J Mol Neurosci       Date:  2016-12-08       Impact factor: 3.444

Review 8.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

9.  Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.

Authors:  B P Morgan; M Griffiths; H Khanom; S M Taylor; J W Neal
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

10.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.